Premier Health Reports 2024 First Quarter Results
Adjusted EBITDA for the quarter was $2.6M ($1.5M for the same period in 2022), despite acquisition costs of around $650K in the quarter and only 52 days of contribution from SSI.
- Adjusted EBITDA for the quarter was $2.6M ($1.5M for the same period in 2022), despite acquisition costs of around $650K in the quarter and only 52 days of contribution from SSI.
- Net Loss for the quarter was $0.2M ($0.4M for the same period in 2022); resulting from acquisition costs and higher financing costs.
- The first quarter of 2024 was marked by the largest acquisition and refinancing PHA has completed so far.
- In that context there is still a lot of consolidation possible in Canada and we are eager to pursue our growth outside Quebec,” said Martin Legault, CEO of Premier Health.